Skip to main content
Signal8

HAMBURG MARGARET A

SEC insider (Form 3/4/5 filer). CIK 0001266917. Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY). 2 reported Form 4/5 transactions since Sep 2024; latest on May 20, 2026. Located in CAMBRIDGE, MA.

Companies HAMBURG MARGARET A has filed insider reports for

  • ALNYLAM PHARMACEUTICALS, INC. (ALNY): Director
HAMBURG MARGARET A profile photo

HAMBURG MARGARET A

CIK: 0001266917

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALNYLAM PHARMACEUTICALS, INC. logo
ALNY

ALNYLAM PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • ALNYLAM PHARMACEUTICALS, INC. logo
    ALNY

    ALNYLAM PHARMACEUTICALS, INC.

    May 20, 2026
    Award
    Direct
    671 shares-
  • ALNYLAM PHARMACEUTICALS, INC. logo
    ALNY

    ALNYLAM PHARMACEUTICALS, INC.

    May 8, 2025
    Award
    Direct
    775 shares-

1-2 of 2